Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Tango Therapeutics, Inc. | Director | Common Stock | 14.7K | $112K | $7.61 | Jun 5, 2024 | Direct |
Tango Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 28.1K | Jun 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TNGX | Tango Therapeutics, Inc. | Jun 5, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
TNGX | Tango Therapeutics, Inc. | Aug 29, 2023 | 2 | $0 | 4 | Aug 31, 2023 | Director |
TNGX | Tango Therapeutics, Inc. | Aug 29, 2023 | 0 | $0 | 3 | Aug 31, 2023 | Director |